Is AXA undervalued compared to its fair value and its price relative to the market?
48.7%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CS (€23.71) is trading below our estimate of fair value (€46.18)
Significantly Below Fair Value: CS is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CS is poor value based on its PE Ratio (18.9x) compared to the XE Insurance industry average (14.2x).
PE vs Market: CS is good value based on its PE Ratio (18.9x) compared to the French market (25.7x).
Price to Earnings Growth Ratio
PEG Ratio: CS is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: CS is good value based on its PB Ratio (0.8x) compared to the XE Insurance industry average (1.1x).
Future Growth
How is AXA forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
17.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CS's forecast earnings growth (17.5% per year) is above the savings rate (0.4%).
Earnings vs Market: CS's earnings (17.5% per year) are forecast to grow slower than the French market (21.4% per year).
High Growth Earnings: CS's earnings are forecast to grow, but not significantly.
Revenue vs Market: CS's revenue is expected to decline over the next 3 years (-2.5% per year).
High Growth Revenue: CS's revenue is forecast to decline over the next 3 years (-2.5% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CS's Return on Equity is forecast to be low in 3 years time (11.7%).
Past Performance
How has AXA performed over the past 5 years?
-18.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CS has high quality earnings.
Growing Profit Margin: CS's current net profit margins (2.7%) are lower than last year (2.7%).
Past Earnings Growth Analysis
Earnings Trend: CS's earnings have declined by 18% per year over the past 5 years.
Accelerating Growth: CS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: CS had negative earnings growth (-17.5%) over the past year, making it difficult to compare to the Insurance industry average (-12.1%).
Return on Equity
High ROE: CS's Return on Equity (3.9%) is considered low.
Financial Health
How is AXA's financial position?
Financial Position Analysis
Short Term Liabilities: CS's short term assets (€126.9B) do not cover its short term liabilities (€213.1B).
Long Term Liabilities: CS's short term assets (€126.9B) do not cover its long term liabilities (€506.1B).
Debt to Equity History and Analysis
Debt Level: CS's debt to equity ratio (76.8%) is considered high.
Reducing Debt: CS's debt to equity ratio has increased from 49.3% to 76.8% over the past 5 years.
Debt Coverage: CS's debt is well covered by operating cash flow (38.9%).
Interest Coverage: CS's interest payments on its debt are well covered by EBIT (6.2x coverage).
Balance Sheet
Dividend
What is AXA current dividend yield, its reliability and sustainability?
6.03%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CS's dividend (6.03%) is higher than the bottom 25% of dividend payers in the French market (1.28%).
High Dividend: CS's dividend (6.03%) is in the top 25% of dividend payers in the French market (3.93%)
Stability and Growth of Payments
Stable Dividend: CS's dividend payments have been volatile in the past 10 years.
Growing Dividend: CS's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its high payout ratio (114%), CS's dividend payments are not well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CS's dividends in 3 years are forecast to be covered by earnings (54.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
3.9yrs
Average management tenure
CEO
Thomas Buberl (47 yo)
4.58yrs
Tenure
€4,038,983
Compensation
Dr. Thomas Buberl, Ph.D. has been Independent Director of International Business Machines Corporation since April 28, 2020. Dr. Buberl served as Chairman of the Board at AXA Equitable Holdings, Inc., since...
CEO Compensation Analysis
Compensation vs Market: Thomas's total compensation ($USD4.83M) is about average for companies of similar size in the French market ($USD3.92M).
Compensation vs Earnings: Thomas's compensation has been consistent with company performance over the past year.
Leadership Team
Experienced Management: CS's management team is considered experienced (3.9 years average tenure).
Board Members
Experienced Board: CS's board of directors are considered experienced (4.6 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
AXA SA's company bio, employee growth, exchange listings and data sources
AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal ...
Company Analysis and Financial Data Status
All financial data provided by Standard & Poor's Capital IQ.
Data
Last Updated (UTC time)
Company Analysis
2021/04/16 18:08
End of Day Share Price
2021/04/16 00:00
Earnings
2020/12/31
Annual Earnings
2020/12/31
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.